Login Register Cart 0
Generic placeholder image

Current Hypertension Reviews

Editor-in-Chief

ISSN (Print): 1573-4021
ISSN (Online): 1875-6506

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Association of Newly Diagnosed Hypertension and Polypharmacy with Frailty in a Tertiary Hospital Patients from Maracaibo City, Venezuela

Author(s): Juan Salazar*, Isabel Borges*, Alejandra Rivas-Motenegro, Nelson Villasmil-Hernandez, Manuel Nava and Roberto Añez

Volume 18, Issue 1, 2022

Published on: 30 November, 2021

Page: [85 - 90] Pages: 6

DOI: 10.2174/1573402117666211005122757

Price: $65

Abstract

Background: As a syndrome of physiological vulnerability and multifactorial progressive decline tightly related to age, frailty has been associated with several illnesses, and in particular cardiovascular disease.

Objective: To assess the factors associated with the frailty syndrome in older adults evaluated in the outpatient clinic of a tertiary hospital from Maracaibo city, Venezuela.

Materials and Methods: An observational, analytical, cross-sectional study was performed on subjects of both genders, over 60 years old that went to the Internal Medicine outpatient clinic of the Hospital General del Sur “Dr. Pedro Iturbe” from Maracaibo city, Venezuela. Sampling was performed via a non-probabilistic, intentional method. For each subject with frailty or pre-frailty, a control subject was selected in a 1:1 ratio according to gender; several risk factors were interrogated. The state of frailty was determined through the FRAIL scale.

Results: Of the 201 assessed patients, 49.3% (n=99) were non-frail, 19.9% (n=40) were pre-frail and 30.8% (n=62) were frail. The population's overall age was 68.8±6.8 in non-frails, 69.1±7.7 in pre-frails, and 68.6±7.1 in frails. In the multivariate analysis, subjects with frailty and pre-frailty were most likely to be receiving polypharmacy (OR: 2.36, CI95%: 1.05-5.37; P=0.04) and have hypertension during the study (OR: 10.19, CI95%: 3.86-26.89; P<0.01).

Conclusion: The newly diagnosed hypertension and presence of polypharmacy were the factors most associated with frailty and pre-frailty in older adults evaluated in a tertiary hospital from Maracaibo city, Venezuela.

Keywords: Frailty, elderly, hypertension, severity, polypharmacy, pre-frailty.

« Previous
[1]
Departamento de Asuntos Económicos y Sociales de las Naciones Unidas. La situación demográfica en el mundo, Informe conciso. 2020. Available:http://www.un.org/en/development/desa/population/publications/pdf/trends/Concise%20Report%20on%20the%20World%20Populatin%20Situation%202014/es.pdfAccess date: 11/01/2020
[2]
Instituto Nacional de Estadística. La transición demográfica de la República Bolivariana de Venezuela 2000-2050. 2020; 2000>-50. Available: http://www.ine.gov.ve/documentos/Demografia/Censo2011/Boletin_Transicion_Demograf/BoletinTransDemogRBV-2000-2050.pdfAccess date: 11/01/2020
[3]
Silva JC, Moraes ZV, Silva C, et al. Understanding red blood cell parameters in the context of the frailty phenotype: Interpretations of the FIBRA (Frailty in Brazilian Seniors) study. Arch Gerontol Geriatr 2014; 59(3): 636-41.
[http://dx.doi.org/10.1016/j.archger.2014.07.014] [PMID: 25236441]
[4]
Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: A call to action. J Am Med Dir Assoc 2013; 14(6): 392-7.
[http://dx.doi.org/10.1016/j.jamda.2013.03.022] [PMID: 23764209]
[5]
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56(3): M146-56.
[http://dx.doi.org/10.1093/gerona/56.3.M146] [PMID: 11253156]
[6]
Fraser B, Willer H. Venezuela: Aid needed to ease health crisis. Lancet 2016; 388(10048): 947-9.
[http://dx.doi.org/10.1016/S0140-6736(16)31523-9] [PMID: 27598666]
[7]
García M, Moreno M. Síndrome de fragilidad: Un desafío para la venezuela del siglo XXI. Revista arbitrada interdisciplinaria de ciencias de la salud. SALUD Y VIDA 2019; 3(5): 60-92.
[http://dx.doi.org/10.35381/s.v.v3i5.253]
[8]
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189-98.
[http://dx.doi.org/10.1016/0022-3956(75)90026-6] [PMID: 1202204]
[9]
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged: The index of ADL, a standardized measure of biological and psychosocial function. JAMA 1963; 185(12): 914-9.
[http://dx.doi.org/10.1001/jama.1963.03060120024016] [PMID: 14044222]
[10]
Rosas-Carrasco O, Cruz-Arenas E, Parra-Rodríguez L, García- González AI, Contreras-González LH, Szlejf C. Cross-cultural adaptation and validation of the FRAIL scale to assess frailty in mexican adults. J Am Med Dir Assoc 2016; 17(12): 1094-8.
[http://dx.doi.org/10.1016/j.jamda.2016.07.008] [PMID: 27567463]
[11]
Salazar J, Bello L, Toledo A, et al. Comportamiento epidemiológico de la automedicación y polifarmacia en individuos adultos del sector Dalia de Fernández, Municipio San Francisco. Arch Venez Farmacol Ter 2013; 32(1): 1-15.
[12]
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39(33): 3021-104.
[http://dx.doi.org/10.1093/eurheartj/ehy339] [PMID: 30165516]
[13]
Rodríguez K, Reales L. Síndrome de fragilidad y sus variables asociadas. Med Interna (Caracas) 2016; 32(4): 272-8.
[14]
Woods NF, LaCroix AZ, Gray SL, et al. Frailty: Emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc 2005; 53(8): 1321-30.
[http://dx.doi.org/10.1111/j.1532-5415.2005.53405.x] [PMID: 16078957]
[15]
Gómez C, Vega-Quiroga S, Bermejo-Pareja F, Medrano MJ, Louis ED, Benito-León J. Polypharmacy in the elderly: A marker of increased risk of mortality in a population-based prospective study (NEDICES). Gerontology 2015; 61(4): 301-9.
[http://dx.doi.org/10.1159/000365328] [PMID: 25502492]
[16]
Gutiérrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero Á, Inzitari M, Martínez-Velilla N. The relationship between frailty and polypharmacy in older people: A systematic review. Br J Clin Pharmacol 2018; 84(7): 1432-44.
[http://dx.doi.org/10.1111/bcp.13590] [PMID: 29575094]
[17]
Aprahamian I, Sassaki E, Dos Santos MF, et al. Hypertension and frailty in older adults. J Clin Hypertens (Greenwich) 2018; 20(1): 186-92.
[http://dx.doi.org/10.1111/jch.13135] [PMID: 29105991]
[18]
Kang MG, Kim SW, Yoon SJ, Choi JY, Kim KI, Kim CH. Association between frailty and hypertension prevalence, treatment, and control in the elderly korean population. Sci Rep 2017; 7(1): 7542.
[http://dx.doi.org/10.1038/s41598-017-07449-5] [PMID: 28790349]
[19]
Bastos-Barbosa RG, Ferriolli E, Coelho EB, Moriguti JC, Nobre F, Lima NK. Association of frailty syndrome in the elderly with higher blood pressure and other cardiovascular risk factors. Am J Hypertens 2012; 25(11): 1156-61.
[http://dx.doi.org/10.1038/ajh.2012.99] [PMID: 22810844]
[20]
Koizumi Y, Hamazaki Y, Okuro M, et al. Association between hypertension status and the screening test for frailty in elderly community-dwelling Japanese. Hypertens Res 2013; 36(7): 639-44.
[http://dx.doi.org/10.1038/hr.2013.7] [PMID: 23446774]

Rights & Permissions Print Cite
Article Metrics
21
1
© 2024 Bentham Science Publishers | Privacy Policy